Macrophage Markers in Periodontal and Peri-implant Health and Disease

NCT05242354 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 36

Last updated 2023-05-18

Study results available
· View outcomes & findings →

Summary

Macrophage surface markers (CD80, CD163 and CD206) will be evaluated in periodontally healthy gingiva, healthy peri-implant mucosa, and periodontitis and peri-implantitis lesions.

Conditions

  • Peri-Implantitis
  • Periodontitis

Sponsors & Collaborators

  • University of Turku

    collaborator OTHER
  • Biruni University

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-03-01
Primary Completion
2021-12-31
Completion
2021-12-31

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05242354 on ClinicalTrials.gov